Dogwood Therapeutics increases CFO Angela Walsh's base salary to $321,903

Dogwood Therapeutics, Inc.

Board approved CFO salary increase from $279,916 to $321,903 per year.
Increase effective July 1, 2025, based on peer company compensation review.
Ms. Walsh remains CFO, Corporate Secretary and Treasurer.

item 5.02

Source: SEC EDGAR

accession 0001558370-25-009060

view filing index on sec.gov

view primary document

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.